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Background: Trials of interventions for PPH prevention and treatment rely on different measurement methods for
the quantification of blood loss and identification of PPH. This study’s objective was to compare measures of blood
loss obtained from two different measurement protocols frequently used in studies.
Methods: Nine hundred women presenting for vaginal delivery were randomized to a direct method (a calibrated
delivery drape) or an indirect method (a shallow bedpan placed below the buttocks and weighing the collected
blood and blood-soaked gauze/pads). Blood loss was measured from immediately after delivery for at least one
hour or until active bleeding stopped.
Results: Significantly greater mean blood loss was recorded by the direct than by the indirect measurement
technique (253.9 mL and 195.3 mL, respectively; difference = 58.6 mL (95% CI: 31–86); p < 0.001). Almost twice as
many women in the direct than in the indirect group measured blood loss > 500 mL (8.7% vs. 4.7%, p = 0.02).
Conclusions: The study suggests a real and significant difference in blood loss measurement between these
methods. Research using blood loss measurement as an endpoint needs to be interpreted taking measurement
technique into consideration.
Trial registration: This study has been registered at clinicaltrials.gov as NCT01885845.
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Post-partum hemorrhage (PPH) is a leading cause of
maternal mortality and morbidity around the world [1].
Accurate assessment of blood loss is important for con-
ducting research on the effectiveness of different ap-
proaches to the prevention and treatment of PPH.
Research has shown that whether or not blood loss is
measured may influence reported PPH rates [2]. How-
ever, the way in which blood loss is measured may also
impact the measurement itself. These differences in
measurement techniques may have important implica-
tions for our understanding of reported PPH rates, the
evaluation of prevention and treatment strategies, and
estimates of prevented PPH.* Correspondence: tshochet@gynuity.org
2Gynuity Health Projects, New York, NY, USA
Full list of author information is available at the end of the article
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distribution, and reproduction in any mediumSeveral techniques for measuring blood loss have been
used in research trials of PPH prevention and treatment
methods. Visual estimation has been found to be highly
inaccurate with substantial under-estimation of blood loss
at high volumes of loss [3,4]. A second method employs
an indirect technique with collection of blood and blood-
soaked material into a vessel. The vessel is then weighed
and an equivalent volume calculated. A systematic review
conducted in 2010 identified more than 20 trials that had
employed this method [5]. More recently, five studies have
employed a direct technique that allows the provider to
assess the blood loss as it accumulates in a calibrated re-
ceptacle (usually a drape) beneath the woman [6-10].
Although both direct and indirect methods have been
widely used in clinical studies, no research has directly
compared the two blood measurement techniques to as-
sess if they produce comparable results. Understanding
the equivalency or systematic differences of methods ofntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited.
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ings in research that uses blood loss as an endpoint. This
study sought to conduct such a comparison.
Methods
This study was a randomized trial to evaluate the meas-
urement of blood loss after delivery using two different
measurement techniques: a direct method, the Excellent
BRASSS-V Drape™, whereby the amount of blood is
measured at the time of bleeding (see Figure 1); and an
indirect method involving the weight and measurement
of blood and blood-soaked materials following the cessa-
tion of bleeding. This study was purely an assessment of
measurement tools and not an evaluation of the effect of
the measurement technique on provider practice or
blood loss interpretation. We assumed that in a large
sample of normal vaginal deliveries randomized only to
a difference in blood measurement techniques, the mean
blood loss recorded would not be significantly different
if the two methods had the same reliability.Figure 1 Photo of the Excellent BRASSS-V Drape™, a blood collectionAll women aged 18 and older presenting at the study
site (KEM Hospital in Pune, India) for an imminent vagi-
nal delivery were considered eligible and were invited to
join the study. Women who agreed to participate were
randomized to one of the two measurement methods.
Cards indicating group allocation were placed in opaque
sequentially numbered envelopes, randomized in blocks
of 10 via a computerized randomization sequence gener-
ated in New York by Gynuity Health Projects staff. Enve-
lopes were opened by study staff after enrollment. All
participants received the standard care provided during
the third stage of labor at the study hospital. Provider
actions related to the prevention or treatment of PPH
(including blood loss interpretation) were as per pro-
vider preference and standard hospital practice and not
dictated by the study protocol. Standard active manage-
ment at KEM Hospital is 10 units oxytocin IM or IV
immediately after the birth of the shoulder of the baby.
Any participant who was referred for a cesarean section
was withdrawn from the study post-randomization; thedrape with a calibrated collection pouch.
Figure 2 Flowchart of study participation.
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pendently by each provider. Enrollment continued until
blood loss in 900 women was measured. The hospital
received IRB approval from the KEM Research Ethics
Committee and all participants signed informed con-
sent. This study was registered retrospectively on June
19, 2013, at clinicaltrials.gov as NCT01885845.
For women randomized to the direct method (using
the Excellent BRASSS-V Drape™), blood measurement
began immediately after delivery and cord clamping.
The calibrated delivery drape was placed under the but-
tocks of the woman and tied around her waist with the
funnel portion hanging down between her legs. Blood
loss was measured for at least one hour or, if bleeding
continued after one hour, until active bleeding stopped.
When active bleeding stopped, providers examined the
drape and recorded the level indicated.
For women randomized to the indirect method proto-
col, a sheet with plastic backing was placed under the
buttocks just after delivery and cord clamping. The sheet
drained into a metal basin placed on a shelf below the
delivery table. Blood loss was collected in the basin for
at least one hour or, if bleeding continued after one
hour, until active bleeding stopped. After bleeding
stopped, all blood-soaked gauze pieces and mops were
counted and then placed in the collection basin. The
basin was placed on an electronic scale and weighed.
The weight of the blood was assessed by subtracting the
initial weight of the basin, gauzes and mops from the
total weight of the soaked materials assuming that one
gram is equivalent to 1 mL.
Hemoglobin measurements were taken at admission
for delivery and at approximately twenty-four hours
post-delivery. Hemoglobin was measured with an auto-
mated flow cytometric method on a coulter machine,
the standard method used at KEM hospital. Study staff
also recorded the amount of IV fluids, any transfusion
received, time of IV removal, and time of hemoglobin
assessment.
This study was powered to test the difference in mean
blood loss measurement during the third stage of labor
with the two techniques described above. We assumed a
mean blood loss of 450 mL with the direct method and
500 mL with the indirect method, with a standard devi-
ation of approximately 265 mL. We determined that a
sample size of 900 women, 450 women in each arm,
would allow us to test a mean difference of 50 mL with
80 percent power and 5 percent probability that we
would incorrectly find a difference in the mean blood
loss measured with each technique.
Data on demographics, active management, blood loss,
and hemoglobin levels were collected by research staff
and compared between the two study groups. Wilcoxon
rank-sum tests, Fisher’s exact tests, and Pearson’s chi-squared tests were run as appropriate to compare fre-
quencies and means. We also conducted linear and logis-
tic regression. All data were entered into Statistics
Package for Social Sciences (SPSS, Version 13.0, Chicago,
IL). Analyses were conducted using Stata (Version 11,
College Station, TX) and SPSS, Version 20.0.
Results
Eleven hundred and ninety-five women were enrolled in
the study between January 2006 and September 2007 (see
Figure 2). Following randomization, 295 women were
withdrawn from the study, mostly because of the pro-
vider’s decision to perform Caesarean section (n = 256).
Other reasons for withdrawal included provider’s decision
for other clinical reasons (n = 35), and woman’s choice
(n = 4). The remaining 900 participants were equally di-
vided between the two study groups. There were no sig-
nificant differences in background characteristics or
delivery details between the study arms (see Table 1).
All women received oxytocin as part of active manage-
ment of the third stage of labor (see Table 2). Additional
uterotonics included misoprostol (Direct: 11.8%; Indir-
ect: 10.0%), carboprost (Direct: 2.0%; Indirect: 1.8%), and
additional doses of oxytocin (Direct: 43.1%; Indirect:
44.7%). Almost all women in both groups (98.9%) had
episiotomies performed. Very few participants required
manual removal of placenta (n = 6), additional surgical
intervention (n = 2), intravenous fluids (n = 10), and/or
blood transfusion (n = 2). There were no significant dif-
ferences between the study groups in interventions
provided.
Statistically significantly greater mean blood loss was
recorded by the direct measurement method than was








(n = 450) (n = 450)
Maternal age in years:
median (range)
25 (17–37) 24 (18–39) 0.58
Parity: median (range) 1 (0–4) 1 (0–4) 0.96
Gravidity: median (range) 2 (1–7) 2 (1–6) 0.69
Gestational age in weeks:
median (range)
39 (28–43) 39 (28–43) 0.62
Nulliparous: % (n) 47.3 (213) 48.9 (220) 0.69
Pre-delivery hemoglobin:
median (range)
11.2 (6.1–15.3)b 11.3 (5.5–16.3)c 0.27
Type of delivery: % (n) 0.90
Vaginal 91.8 (413) 92.2 (415)
Forceps 8.2 (37) 7.8 (35)
Delivery outcome: % (n) > 0.99
Singleton (live birth) 99.3 (447) 99.1 (446)
Twins (live birth) 0.2 (1) 0.4 (2)
Triplets (live birth) 0.2 (1) 0.0 (0)
Singleton (stillborn) 0.2 (1) 0.2 (1)
Twins (stillborn) 0.0 (0) 0.2 (1)
One or more complications
(including vaginal or
perineal tears): % (n)
1.1 (5) 2.4 (11) 0.21
aCalculated with the Wilcoxon rank-sum test and Fisher’s exact test.
bn = 422.
cn = 416.









(n = 450) (n = 450)
Uterotonics used for
active management
Oxytocinb 100.0 (450) 100.0 (450) na
Misoprostol 0.9 (4) 1.1 (5) > 0.99
Carboprost 0.7 (3) 0.2 (1) 0.37
Additional uterotonics
for treatment
Oxytocin 43.1 (194) 44.7 (201) 0.69
Misoprostol 11.8 (53) 10.0 (45) 0.45
Carboprost 2.0 (9) 1.8 (8) > 0.99
Episiotomy performed 98.9 (445) 98.9 (445) > 0.99
Manual removal of
placenta performed
0.4 (2) 0.9 (4) 0.69
Other surgical intervention
performed
Internal iliac ligation 0.0 (0) 0.2 (1) > 0.99
Resuturing of episiotomy 0.2 (1) 0.0 (0) > 0.99
Blood transfusion given 0.2 (1) 0.2 (1) > 0.99
Intravenous fluids given
for PPH treatment
0.9 (4) 1.3 (6) 0.75
aCalculated with Fisher’s exact test.
bAs per the KEM protocol, all women receive 10units of oxytocin im after
delivery as a standard routine management method. If the uterus is not well
contracted or there is visual excessive blood loss women receive 400 mcg of
oral misoprostol or 150mcg of carboprost im.









(n = 450) (n = 450)
Blood loss: % (n) < 0.001
0–100 25.8 (116) 41.1 (185)
101–200 30.9 (139) 32.2 (145)
201–300 19.1 (86) 11.3 (51)
301–400 9.3 (42) 9.3 (42)
401–500 6.2 (28) 1.3 (6)
> 500 8.7 (39) 4.7 (21)
Mean blood loss:








mean ± SD (range)
−0.8 ± 1.4 (−7.0–3.8)c −0.7 ± 1.5 (−7.2–3.2)d 0.19
aBlood loss for direct method measured in milliliters and blood loss for
indirect method measured in grams (1 g = 1 mL).
bCalculated with Pearson’s chi-squared test and Wilcoxon rank-sum test.
cn = 397.
dn = 384.
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(253.9 mL and 195.3 mL, respectively; p < 0.001) (see
Table 3). The difference in mean blood loss between
methods was 58.6 mL (95% CI: 31.1 – 86.1) (data not
shown). In addition, almost twice as many women in the
direct than in the indirect group measured a blood loss
of more than 500 mL (8.7% vs. 4.7%, p = 0.02). We con-
ducted a linear regression (of blood loss in mL) and a
logistic regression (of blood loss > 500 mL), controlling
for woman’s age, parity, gestational age, and pre-
delivery hemoglobin level. Method of measurement
retained its significant difference in both (linear regres-
sion: p < 0.001, logistic regression: p = 0.04; data not
shown). Participants in both arms used the same aver-
age number of mops (0.8; p = 0.26) and the same aver-
age number of gauzes during the delivery (3.8; p = 0.93)
(data not shown). The mean change in hemoglobin did
not differ significantly between the study groups (direct
method: −0.8, indirect method: −0.7; p = 0.19).
Discussion
This study was designed to compare two common
methods for measuring postpartum blood loss in research
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significant difference in blood loss measurement be-
tween the two methods. The mean measured blood loss
was significantly greater in the direct measurement
group with nothing to indicate (i.e., differences in the
populations, number of mops used, or change in Hgb
levels) that the measurements should have been differ-
ent, implying that the measurement technique itself
may be the cause of the difference in noted blood loss
between the two groups.
This is the first study to present such a comparison.
This trial provides new results important for the inter-
pretation of studies using obstetric blood loss measure-
ment as an endpoint. Studies aimed at prevention and
treatment of PPH need to take into consideration the
differences in measurement produced by these two tech-
niques and interpret their findings accordingly. If using
the direct approach, for example, adjustments will need
to be made when comparing findings with past literature
that utilized indirect techniques. In addition, meta-
analyses of blood loss will need to incorporate measure-
ment technique into their methodologies.
Rates of PPH reported in different studies could also
be influenced by measurement method; studies using
the drape, for example, would produce higher rates than
studies using an indirect technique. In studies where the
protocol requires that a woman is treated when her
blood loss reaches a specific amount, often 500 mL, un-
derstanding the variation in blood loss measurement
could change both treatment practices and the total
number of women who receive a given intervention.
A direct comparison of the two measurement tech-
niques would compare the assessments of the two meas-
urement methods on the same patient. This is not
feasible, however. The background characteristics of the
two measurement groups suggest that the two groups
were similar, and there was no reason to suspect that the
mean recorded blood loss in the two groups would be
different. The same research staff recorded measurement
results for both techniques. Research staff used an elec-
tronic scale to record the weight of the materials in the
indirect measurement group. In the direct arm, staff re-
corded the level indicated on the calibrated drape.
The mean blood loss found in both study arms (Direct:
253.9 mL; Indirect: 195.3 mL) was much lower than antic-
ipated in our projected sample size calculations. The level
of blood loss in this population reflects the near universal
use of oxytocin prophylaxis in contrast to studies of post-
partum hemorrhage conducted in community-based set-
tings. Still, our study had sufficient power to detect a
significant difference in mean blood loss between the two
measurement techniques.
Some studies using the indirect technique have relied
on a different formula to convert blood loss in grams toblood loss in milliliters. Althabe et al. divided the weight
in grams by 1.06 (blood density in grams per milliliters)
rather than 1.0 as used in this study [11]. Our calcula-
tion is conservative and if we adjusted for the weight of
blood in the indirect method then the difference in
blood loss measured with the two techniques would be
even greater.
Different mechanisms may have contributed to the dif-
ference in mean blood loss between the two study arms.
The calibrated drape used in this study starts at the
50 mL measurement and increases in increments of
50 mL to 1000 mL. Between 1000 and 2000 mL, read-
ings are in increments of 100 mL and between 2000 and
3000 in increments of 200 mL. The less precise mea-
sures may result in heaping of measurements at 50 mL
increments for cases with less than 1000 mL blood loss
(especially among women with very little blood loss) and
at 100 and 200 mL increments for cases with high levels
of blood loss. This may have contributed to the higher
measurements with the direct method when compared
to the indirect method that allowed for more precise
readings with the digital scale.
Blood loss was collected in the basin for at least one
hour or, if bleeding continued after one hour, until active
bleeding stopped. One limitation to the study is that
providers were not asked to record the start and stop time
for the measurement of bleeding. It is possible that meas-
urement of bleeding in the bedpan or indirect group was
curtailed as women were uncomfortable with the bedpan
and blood measurement ceased after one hour. Though
any additional blood measured after the cessation of active
bleeding would likely be minimal and not account for the
differences seen here. Additionally, there may have been
losses of fluids as blood was transferred for measurement.Conclusions
Based on these results, we conclude that there may be an
important difference in recorded blood loss between the
direct and indirect measurement methods. Measurement
technique must be considered both when developing re-
search protocols that utilize blood loss measurement as an
endpoint as well as when evaluating previous studies that
report quantitative blood loss after delivery.Competing interests
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